SWOG clinical trial number
CTSU/EA3161

A Phase II/III Randomized Study of Maintenance Nivolumab Versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPCA

Open
Phase
Abbreviated Title
A Phase II/III Randomized Study of Maintenance Nivolumab Versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPCA
Status Notes
SWOG Activated: 1/21/2020
Activated
06/20/2019

Research committees

Early Therapeutics & Rare Cancers
Head and Neck Cancer

Treatment

Cisplatin Nivolumab